Semi-Annual Statement Of Income And Retained Earnings

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7324025

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
9,513,000,000 JPY
JPY
1,373,000,000 JPY
9,513,000,000 JPY
8,140,000,000 JPY
9,784,000,000 JPY
6,707,000,000 JPY
7,998,000,000 JPY
8,365,000,000 JPY
JPY
7,998,000,000 JPY
1,290,000,000 JPY
Non-operating income
Non-operating income
543,000,000 JPY
540,000,000 JPY
616,000,000 JPY
780,000,000 JPY
Non-operating expenses
Non-operating expenses
106,000,000 JPY
104,000,000 JPY
51,000,000 JPY
51,000,000 JPY
Ordinary profit (loss)
9,951,000,000 JPY
10,220,000,000 JPY
8,930,000,000 JPY
8,727,000,000 JPY
Extraordinary income
Extraordinary income
14,000,000 JPY
14,000,000 JPY
4,000,000 JPY
4,000,000 JPY
Extraordinary losses
Extraordinary losses
168,000,000 JPY
168,000,000 JPY
354,000,000 JPY
1,914,000,000 JPY
Profit (loss) before income taxes
9,796,000,000 JPY
10,065,000,000 JPY
8,580,000,000 JPY
6,817,000,000 JPY
Income taxes - current
1,926,000,000 JPY
1,911,000,000 JPY
3,980,000,000 JPY
3,998,000,000 JPY
Income taxes - deferred
-155,000,000 JPY
-328,000,000 JPY
-2,165,000,000 JPY
-2,621,000,000 JPY
Profit (loss)
8,483,000,000 JPY
8,025,000,000 JPY
8,483,000,000 JPY
8,483,000,000 JPY
8,483,000,000 JPY
6,765,000,000 JPY
6,765,000,000 JPY
6,765,000,000 JPY
6,765,000,000 JPY
5,440,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.